DNA-loaded chitosan oligosaccharide nanoparticles with enhanced permeability across Calu-3 cells.

about

DNA-loaded chitosan oligosaccharide nanoparticles with enhanced permeability across Calu-3 cells.

Item

http://www.wikidata.org/entity/Q39182355

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

DNA-loaded chitosan oligosacch ...... meability across Calu-3 cells.

@en

DNA-loaded chitosan oligosacch ...... meability across Calu-3 cells.

@nl

type

Item

label

DNA-loaded chitosan oligosacch ...... meability across Calu-3 cells.

@en

DNA-loaded chitosan oligosacch ...... meability across Calu-3 cells.

@nl

prefLabel

DNA-loaded chitosan oligosacch ...... meability across Calu-3 cells.

@en

DNA-loaded chitosan oligosacch ...... meability across Calu-3 cells.

@nl

P1476

DNA-loaded chitosan oligosacch ...... rmeability across Calu-3 cells

@en

P2093

Caihong Zheng

http://www.w3.org/2001/XMLSchema#string

Fengying Chen

http://www.w3.org/2001/XMLSchema#string

George P H Leung

http://www.w3.org/2001/XMLSchema#string

King-Ho Cheung

http://www.w3.org/2001/XMLSchema#string

Wanling Liang

http://www.w3.org/2001/XMLSchema#string

Yingying Xu

http://www.w3.org/2001/XMLSchema#string

Yiqing Ye

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties.

Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.

Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?

Targeted gene silencing using RGD-labeled chitosan nanoparticles.

Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.

Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses.

Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3.

Intranasal delivery: physicochemical and therapeutic aspects.

Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents.

Nucleic acid delivery with chitosan and its derivatives.

P304

474-486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/1061186X.2013.766885

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jenny K.W. Lam

P577

2013-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23480724

http://www.w3.org/2001/XMLSchema#string

P921

oligosaccharide